Biocon Biologics is a fully integrated global biosimilars company committed to transforming healthcare by enabling affordable access to high-quality biosimilars for millions of patients worldwide. As a subsidiary of Biocon Ltd., it leverages cutting-edge science and advanced R&D capabilities to develop and commercialize biosimilars across various therapeutic areas, including oncology, diabetes, and immunology.